DOI:
10.1055/s-00000094
Zeitschrift für Gastroenterologie
LinksClose Window
References
Poordad F, Lawitz E, Gutierrez JA et al.
C-SWIFT: Grazoprevir/Elbasvir plus Sofosbuvir in cirrhotic and noncirrhotic, treatment-naive patients with hepatitis C virus genotype 1 infection, for durations of 4, 6 OR 8 weeks and genotype 3 infection for durations of 8 or 12 weeks.
Journal of hepatology 2015;
62: S192-S193
We do not assume any responsibility for the contents of the web pages of other providers.